anche oggi il nostro meno 10 quotidiano...fino a quando scende zero notizie
anche oggi il nostro meno 10 quotidiano...fino a quando scende zero notizie
la cosa bella dei forum e che ci son sempre quelli che non sbaglianoi mai...a 16 le faccio fuori,,,,,buona giornata
- Registrato
- 17/7/20
- Messaggi
- 388
- Punti reazioni
- 13
a 16?
- Registrato
- 17/7/20
- Messaggi
- 388
- Punti reazioni
- 13
Ma ci sono news? Che titolo pazzo. Era da entrare a piene mani 2 ore fa e vendere adesso milionari
gliele hai mollate a 12 o sei ancora dentro ad 8? ^^
- Registrato
- 17/7/20
- Messaggi
- 388
- Punti reazioni
- 13
mah... titolo scommessa... purtroppo il sentiment è che il prestito se lo scordano... altrimenti non scenderebbero ogni giorno..... se poi però lo danno e si è entrati a sti prezzi, allora è come fare 13 al totocalcio
ilovepablo
Utente Registrato
- Registrato
- 5/11/12
- Messaggi
- 1.131
- Punti reazioni
- 28
KODK +37% in After.....
Riparte la giostra?
Riparte la giostra?
cochecito
Utente Registrato
- Registrato
- 15/6/06
- Messaggi
- 9.096
- Punti reazioni
- 477
An independent review has raised concerns about Eastman Kodak’s corporate governance but found no evidence of insider trading when its top executive and a board member bought shares before the stock surged on news of a possible $765m loan from the US government.
Jim Continenza, Kodak’s chairman and chief executive, and Philippe Katz, a board member, bought shares in June, and Mr Continenza was awarded stock options on July 27, the day before the company said it was nearing a deal with the government to become a manufacturer of generic drug ingredients.
That announcement briefly sent the stock soaring 15-fold, transforming the value of insiders’ holdings and drawing scrutiny of the stock deals from members of Congress and others. The US International Development Finance Corporation, which was negotiating the loan, said in August that it would not move ahead unless the allegations of wrongdoing were cleared.
Oggi si vola
Jim Continenza, Kodak’s chairman and chief executive, and Philippe Katz, a board member, bought shares in June, and Mr Continenza was awarded stock options on July 27, the day before the company said it was nearing a deal with the government to become a manufacturer of generic drug ingredients.
That announcement briefly sent the stock soaring 15-fold, transforming the value of insiders’ holdings and drawing scrutiny of the stock deals from members of Congress and others. The US International Development Finance Corporation, which was negotiating the loan, said in August that it would not move ahead unless the allegations of wrongdoing were cleared.
Oggi si vola
